Open AccessAcquired von Willebrand syndrome and lymphoproliferative disorders: A case report
Author(s) -
Nicol Christophe,
Raj Leela,
Guillerm Gaëlle,
Couturaud Francis,
Eveillard JeanRichard,
PanPetesch Brigitte
Publication year - 2020
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.2770
Subject(s) - medicine , daratumumab , discontinuation , lymphoproliferative disorders , dermatology , multiple myeloma , pediatrics , immunology , bortezomib , lymphoma
Acquired von Willebrand syndrome is a rare bleeding disorder often secondary to an underlying lymphoproliferative disorder. We report a case in whom response of both the acquired von Willebrand syndrome and smoldering multiple myeloma persist 14 months after daratumumab treatment discontinuation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom